Abstract
Serum immunoglobulin concentration and skin reactivity to at least three recall antigens were determined in 210 patients with chronic myeloid leukemia (CML). Immunoglobulin concentration was normal in the great majority of the patients. Skin tests were negative in 50 of 210 cases (24%). No relationship could be demonstrated between skin reactivity, age, time since diagnosis, WBC, lymphocyte count, and splenectomy. Prior antileukemic therapy was a major factor in determining the response to skin tests.
Original language | English |
---|---|
Pages (from-to) | 59-62 |
Number of pages | 4 |
Journal | Cancer Immunology, Immunotherapy |
Volume | 6 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1979 |
ASJC Scopus subject areas
- Cancer Research
- Immunology
- Oncology